Bank of New York Mellon Corp - SPRING BK PHARMACEUTICALS IN ownership

SPRING BK PHARMACEUTICALS IN's ticker is SBPH and the CUSIP is 849431101. A total of 52 filers reported holding SPRING BK PHARMACEUTICALS IN in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of SPRING BK PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2020$60,000
-9.1%
45,1390.0%0.00%
Q2 2020$66,000
+57.1%
45,1390.0%0.00%
Q1 2020$42,000
+75.0%
45,139
+199.0%
0.00%
Q4 2019$24,000
-53.8%
15,0960.0%0.00%
Q3 2019$52,000
-7.1%
15,0960.0%0.00%
Q2 2019$56,000
-88.2%
15,096
-66.6%
0.00%
Q1 2019$474,000
+4.4%
45,157
+3.1%
0.00%
Q4 2018$454,000
-8.8%
43,789
+5.9%
0.00%
Q3 2018$498,000
+11.7%
41,359
+9.9%
0.00%
Q2 2018$446,00037,6320.00%
Other shareholders
SPRING BK PHARMACEUTICALS IN shareholders Q2 2019
NameSharesValueWeighting ↓
BVF INC/IL 1,301,701$4,803,0000.52%
SECTORAL ASSET MANAGEMENT INC 276,656$1,021,0000.12%
PARSONS CAPITAL MANAGEMENT INC/RI 277,263$1,023,0000.11%
CAXTON CORP 23,821$88,0000.10%
TIEDEMANN ADVISORS, LLC 412,049$1,522,0000.08%
Private Capital Advisors, Inc. 52,335$193,0000.06%
Pegasus Asset Management, Inc. 18,750$69,0000.05%
Hikari Power Ltd 61,336$226,0000.02%
Lee Financial Co 18,750$69,0000.02%
Baker Brothers Advisors 613,144$2,263,0000.02%
View complete list of SPRING BK PHARMACEUTICALS IN shareholders